Skip to content
News
Perspectives
Videos
CE
Sign In
Perspectives
Explore the latest insights, breakthroughs, and expert perspectives in oncology clinical care.
All articles
Bridging the Regulatory Gap: Operationalizing Quality Frameworks in Oncology Real-World Data
A New Milestone for the AI-Powered Cancer Vaccine
Reimagining Oncology Education With Human-Guided AI
Bringing Bispecific Antibodies Into Community Myeloma Care
Beyond the Headlines: AI’s Growing Role in Breast Oncology
Personalizing Surgical Risk Assessment in Lung Cancer With AI
Clinical Trial Enrollment Barriers: Awareness Isn’t the Same as Access
The Fast Track to Efficiency: How Simulation Modeling Improves Oncology Clinic Flow
Making the Match: How AI Improves Clinical Trial Matching
New Paths Forward in Cutaneous T-Cell Lymphoma
Building Trust in Real-World Evidence With AI and High-Quality Data
Immunotherapy Fatigue: Resistance, Retreatment, and When to Stop
Additional Advances in Metastatic Prostate Cancer Research and Treatment
Additional Advances in Extrapulmonary Neuroendocrine Carcinomas
Earlier Detection, Better Outcomes in Ovarian Cancer
Tailoring Diagnostic and Treatment Strategies in Systemic Mastocytosis
Information Overload and the Portal Patient: Managing Physician–Patient Relationships in the Era of Instant Test Results
How a Multi-LLM Ensemble Accelerates Drug Repurposing
One Size Fits One: Personalizing Cancer Prevention Through AI-Enhanced Imaging
The Silent Side Effect: Addressing Ototoxicity in Germ Cell Tumor Treatment
Equity in Preventive Oncology: Practices That Respect Identity and Anatomy
Is Racial and Ethnic Representation in Oncology Clinical Trials Improving?
From Curiosity to Contribution: How Oncologists Can Engage in AI and Innovation
Precision Decisions in NDMM: A Live Virtual Rounds Preview
LGBTQ+ Health Equity: Lessons from a Three-Time Survivor
No One Is Invincible: A Call for Proactive Skin Cancer Screening
Partners in Care: The Community Role in Men’s Cancer Prevention and Treatment
ASCO Voices: Highlighting the Power of Patient Trust
Human Expertise Still Matters in the Age of AI
A New Door in Lung Cancer: Targeting MET Amplification as a Primary Driver
Can Podcasts Help Improve Adoption of HER2-Low Therapies?
Only the First Chapter: Reframing Cancer Survivorship
Multidisciplinary Realities: Tumor Board vs Tuesday Afternoon
Debunking Myths in Breast Cancer Screening
Targeting RAS in Pancreatic Cancer: Emerging Clinical Evidence and the Promise of Next-Generation Inhibitors
Strength in Community: Building Visibility in LGBTQ+ Cancer Care
Can Exercise Lower Lung Cancer Risk?
The Invisible Side of Cancer Treatment
Melanoma Matters: Recognizing Risk, Acting Early, and Advancing Care
Vepdegestrant Approved for ESR1-Mutated, ER-Positive, HER2-Negative Advanced or Metastatic Breast Cancer
The Real World vs The Trial Patient: Bridging the Gap
AI-Driven Pathological Subtyping for Pancreatic Cancer: Moving From Promise to Practical Application
ASCO Genitourinary Cancer Symposium 2026: Prostate Cancer Recap
Patient Experience Week: How Small Moments Make a Big Impact
Measuring Clinical Trial Representation in the Era of Precision Medicine
A Guide to Egg and Embryo Cryopreservation in Oncofertility Care
National Minority Health Month: Equity Begins With Access
Expanding Early Detection of Hepatocellular Carcinoma With HelioLiver
The Power of Community for Women in Science and Research
Exercise for Older Cancer Survivors: Dispelling the Myths and Creating Guidance
AYA Cancer Awareness: Addressing Biological Distinctiveness, Survivorship, and the Whole-Person Approach
Additional Advances in Esophagogastric Cancer Research and Clinical Trials
HER2-Mutant NSCLC Update: Expanded Approval of Zongertinib
Choosing Not to Treat: How Do You Know When the Best Treatment is No Treatment?
MRD and Complete Response End Points: New Guidance for Multiple Myeloma Trials With Rahul Banerjee, MD, FACP, and Nicholas Richardson, DO, MPH
National Doctors Day: Upholding the Human Connection With Jasmin Hundal, MD, MS, MPH, and Matthew Hadfield, DO
Additional Advances in Hemophilia Research and Clinical Trials With Robert F. Sidonio, Jr., MD, MSc
Perioperative Chemoimmunotherapy in Early-Stage NSCLC: From Concept to Clinic With Juliet Meir, MD, and Wint Yan (Arthur) Aung, MD
Nivolumab Plus Chemotherapy Approved for Previously Untreated Hodgkin Lymphoma
The OCTAVIA Problem: Optimizing Cancer Care in the Era of AI
Fueling Survival: The Power of Nutrition in Breast and Prostate Cancer With Jasmin Hundal, MD, MS, MPH, and Stephen Freedland, MD
iNav: How AI-Driven Navigation Is Accelerating Pancreatic Cancer Care With Daniel King, MD, PhD, and Waqas Haque, MD, MPH
Additional Advances in Neuroendocrine Tumor Research and Clinical Trials With Aman Chauhan, MD
Teclistamab Approved for Relapsed or Refractory Multiple Myeloma
International Women’s Day: Sharing Knowledge and Community With Jasmin Hundal and Megan-Claire Chase
Molecular Testing Chaos: Are We Over-Testing, Under-Testing, or Testing the Wrong Things at the Wrong Time?
Oncofertility: Bridging Reproductive Medicine and Cancer Care With Meaghan Delaney, MD, MA
The Hidden Burden of Rarity: Navigating the Rare Cancer Journey With Claire Saxton, MBA
Acalabrutinib With Venetoclax Approved for Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Cholangiocarcinoma Awareness: Immunotherapy, Precision Medicine, and the Importance of Molecular Testing With Kannan Thanikachalam, MD
National Caregivers Day: Navigating Both Sides of the Journey With Heather Badt, MBA, LSS, and Jasmin Hundal, MD, MS, MPH
Additional Advances in Biliary Tract Cancer Research and Advocacy With Melinda Bachini
Working With Cancer: Insights for Employer Support With Hadly Clark and Sabrina Spitaletta
Prevention in Practice: Melanoma, Breast Cancer, and Beyond With Matthew Hadfield, DO, and Jasmin Hundal, MD, MS, MPH
Multicancer Early Detection: Understanding the Science and Promoting Practical Application
Oncology Unfiltered: If a Patient Can’t Afford to Fill the Prescription, Is It Really a Treatment Option
World Cancer Day: United by Uniqueness With Jasmin Hundal, MD, MS, MPH, and Sally Werner, RN, BSN, MSHA
How AI Can Empower Community Oncologists With Kristin Ashcraft and Waqas Haque, MD, MPH
Anitocabtagene Autoleucel in RRMM: Efficacy, Safety, and Improving Access With Krina Patel, MD, MSc
Daratumumab and Hyaluronidase-fihj Plus VRd Approved for Transplant-Ineligible Newly Diagnosed Multiple Myeloma
World Cancer Day: Providing a Patient-Centered Approach Through Together for Supportive Cancer Care With Daneen Sekoni
Additional Advances in Melanoma Research and Clinical Trials With Michael Davies, MD, PhD
Cybersecurity = Patient Safety: How This Plays Out in Oncology
Optimizing Clinical Strategies for Successful Stem Cell Mobilization Outcomes in Multiple Myeloma
Trastuzumab Deruxtecan and Pertuzumab Approved for HER2-Positive Breast Cancer
How Nurse-Led Telehealth Enhances Emotional Recovery for Cancer Survivors With Yolanda VanRiel, PhD, RN
Discovering Systemic Mastocytosis in Practice: A Webinar Preview With Lauren M. Madigan, MD
Bringing Breast Cancer Screening to the Neighborhood With Martha Welman, MD, and Jasmin Hundal, MD, MS, MPH
Advocacy and Innovation at SABCS 2025 With Megan-Claire Chase and Jasmin Hundal, MD, MS, MPH
Navigating MRD as an End Point in Hematologic Malignancies With Rahul Banerjee, MD, FACP, and Nicholas Richardson, DO, MPH
Rucaparib Approved for Metastatic Castration-Resistant Prostate Cancer
Niraparib and Abiraterone Acetate Plus Prednisone Approved for BRCA2-Mutated Metastatic CSPC
Navigating HER2-Mutant NSCLC Pathology and Management: A Webinar Preview With Helena A. Yu, MD, and Maria Arcila, MD
Lisocabtagene Maraleucel Approved for Relapsed or Refractory Marginal Zone Lymphoma
Durvalumab Approved for Resectable Gastric and Gastroesophageal Junction Adenocarcinoma
How AI Is Redefining Lung Cancer Screening Precision
Exploring Breast Cancer Research at ESMO 2025 With Jasmin Hundal, MD, MS, MPH
Pembrolizumab–Enfortumab Vedotin-ejfv Combination Approved for Muscle Invasive Bladder Cancer
Tarlatamab-dlle Approved for Relapsed Extensive-Stage Small Cell Lung Cancer
CAR T in Practice: What Oncologists Need to Know With Ehsan Malek, MD
Advancing Community Oncology in an Era of Uncertainty With Matthew Hadfield, DO, and Jason Hammonds
Manta Cares: Making Cancer Care Personal With Samira Daswani and Waqas Haque, MD, MPH
Evolving Standards in Prostate Cancer: Lessons From ESMO 2025 With Stephen Freedland, MD, and Murilo Luz, MD
Sevabertinib Granted Accelerated Approval for Non-Squamous NSCLC
Epcoritamab-bysp Approved for Relapsed/Refractory Follicular Lymphoma
Setting New Standards in Prostate Cancer Management With EMBARK With Stephen Freedland, MD
Ziftomenib Approved for Relapsed/Refractory AML With Susceptible NPM1 Mutation
Adaptive Intelligence in Prostate Cancer Radiation With Christopher Iannuzzi, MD
Oncology Data Advisor® Welcomes Matthew Hadfield, DO, as Editor in Chief
Navigating New Frontiers in Oncology: What's Next at Oncology Data Advisor With Matthew Hadfield, DO, and Rahul Banerjee, MD, FACP
Daratumumab and Hyaluronidase-fihj Approved for High-Risk Smoldering Multiple Myeloma
Improving Early and Equitable Lung Cancer Detection With Sybil: Mary Pasquinelli, DNP, FNP-BC, CTTS, and Waqas Haque, MD, MPH
Reducing Prostate Cancer Radiation Toxicities With Hydrogel Rectal Spacers With Sean Collins, MD
Revumenib Approved for Relapsed/Refractory AML With Susceptible NPM1 Mutation
Beyond MARS 2: Perspectives on Surgery in Pleural Mesothelioma With Jeffrey Velotta, MD
Improving Oncologic and Genetic Management of Von Hippel-Lindau Disease
Belantamab Mafodotin-blmf Combination Approved for Relapsed/Refractory Multiple Myeloma
Addressing Fear of Recurrence in Breast Cancer Survivorship Care With Armaan Jamal
Beyond the Pink: Turning Breast Cancer Awareness to Action With Kisha Cummings, Megan-Claire Chase, and Jasmin Hundal, MD, MS, MPH
The AI Co-Scientist: A New Paradigm for Discovery in Oncology?
Cemiplimab Approved for Adjuvant Treatment of High-Risk CSCC
Taking a Nuanced Approach to Breast Cancer Screening, Treatment, and Awareness With Matthew Kurian, MD, and Jasmin Hundal, MD, MS, MPH
Charting New Paths in Oncology Informatics With Travis Osterman, DO, and Waqas Haque, MD, MPH
Lurbinectedin Plus Atezolizumab Approved for Maintenance Treatment in ES-SCLC After Induction Therapy
New Horizons in ESR1-Mutated Breast Cancer With Komal Jhaveri, MD, FACP
Pembrolizumab Plus Berahyaluronidase Alfa-pmph Approved for Subcutaneous Administration Across Solid Tumor Indications
World Lung Day: Advancing Equity Through Low-Dose Lung Cancer Screening With Brian Whang, MD
Prescribing Movement: The Role of Women’s Fitness in Oncology With Jasmin Hundal, MD, MS, MPH
Rethinking Cancer Pain Through Oncology and Palliative Medicine Collaboration With Joseph McCollom, DO, and Jasmin Hundal, MD, MS, MPH
The Future of FDA Guidance, Trial Design, and Accelerated Approvals With Matthew Hadfield, DO and Harpreet Singh, MD
EMPOWER-Lung 3: Durable Survival With Cemiplimab/Chemotherapy in Advanced NSCLC With Ana Baramidze, MD, PhD
From Fellow to Attending: Lessons From Year One in Oncology Practice With Matthew Hadfield, DO, and Alankrita Taneja, MD
Selumetinib’s Pediatric Approval Expanded for Neurofibromatosis Type 1 With Symptomatic, Inoperable Plexiform Neurofibromas
Gemcitabine Intravesical System Approved for BCG-Unresponsive Non–Muscle Invasive Bladder Cancer
From Knowledge to Practice: AI's Growing Role in Oncology
From Abstracts to Action: How ASCOmind Streamlines Oncology Insights With Xiaoyan Wang, PhD; William Oh, MD; and Waqas Haque, MD, MPH
Tailoring Treatment and Building Confidence in Management of Hemophilia
Exploring the FDA Approval of Dordaviprone for Mutant Diffuse Midline Gliomas With Patrick Wen, MD
Beyond the Beach: A Guide to Summer Sun Safety With Matthew Hadfield, DO
World Breast Cancer Research Day: How Exercise Improves Gait, Balance, and Quality of Life With Connie Visovsky, PhD, RN, ACNP, FAAN
Zongertinib Granted Accelerated Approval for HER2 TKD–Mutated Non-Squamous NSCLC
Digital Technology and Social Technology: Two Approaches to Reshaping Healthcare
Dordaviprone Granted Accelerated Approval for H3 K27M–Mutant Diffuse Midline Glioma
RP1 and the FDA: A Missed Opportunity in Advanced Melanoma? With Matthew Hadfield, DO, and Justin Moser, MD
Additional Advances in Genetic Counseling and Testing in Cancer Care With Filipa Lynce, MD, and Catherine Skefos, MA, MS, CGC
Highlights of MASCC 2025: Occupational Health, Financial Toxicity, and Patient Advocacy With Jasmin Hundal, MD, MS, MPH
Additional Advances in HER2-Mutated NSCLC With Julia Kathleen Rotow, MD
Breast Cancer Research Highlights at ASCO 2025 With Jasmin Hundal, MD, MS, MPH
Multicancer Early Detection: A Fellow’s Perspective With Waqas Haque, MD, MPH
Advancing Immunotherapy Proficiency in Recurrent/Metastatic HNSCC
What the Oncology Field Can Learn From the CHALLENGE Trial
Additional Advances in MCED Technologies With Charles Vega, MD
Additional Insights in Dedifferentiated Liposarcoma With Richard F. Riedel, MD, and Candace L. Haddox, MD
SurVaxM and the Future of Glioblastoma Treatment With Ajay Abad, MD
AI at ASCO: Updates in Precision, Research, and Prevention
Structuring Electronic Health Record Data Through a Large Language Model Pipeline With Gayathri Namasivayam, PhD
Exploring the Evolution of Neuroendocrine Tumor Diagnostics and Therapeutics: A Webinar Preview With Aman Chauhan, MD
Sunvozertinib Approved for EGFR Exon 20 Insertion Mutation–Positive NSCLC
Can Exercise Be Used as Medicine in Colon Cancer?
Linvoseltamab-gcpt Approved for Relapsed or Refractory Multiple Myeloma
When Disaster Strikes: Developing Emergency Preparedness in Oncology With Manali Patel, MD
Datopotamab Deruxtecan-dlnk Granted Accelerated Approval for EGFR-Mutated NSCLC
Caring for Caregivers’ Well-Being in Gynecologic Cancers With Abigail Zamorano, MD
Tafasitamab-cxix Approved for Relapsed or Refractory Follicular Lymphoma
Guiding Renal Cell Carcinoma Patient Counseling With IMDC Prognostic Factors With David Maj, MBBS, MSc, FRCPC
Celebrating Pride, Advancing Inclusivity: Lessons in LGBTQ+ Cancer Care With Lauren Ghazal, PhD, FNP-BC, and Jasmin Hundal, MD, MS, MPH
Pembrolizumab Approved for Perioperative Treatment of Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
i3 Health and Oncology Data Advisor Publish New Biliary Tract Cancer Guidance in "Hepatology Communications"
Celebrating the Role of Nursing Assistants in Oncology Care and Research With Erika Toledo, Kimberly Hartig-Balderas, and Maria Badillo, MSN, RN, OCN®, CCRP
Navigating Cancer Survivors Through the Continuum of Care With Darcy Burbage, DNP, RN, AOCN®, CBCN®
Mitomycin Intravesical Solution Approved for Low-Grade Non–Muscle Invasive Bladder Cancer
Taletrectinib Approved for ROS1-Positive Non–Small Cell Lung Cancer
Proactive Steps Against Prostate Cancer This Men’s Health Week With Stephen Freedland, MD
Can Social Determinant of Health Data Be Used for Addressing Disparities Yet? With Amy O'Sullivan, PhD
From Terminal to Treatable: Tackling Glioblastoma Disparities at OurBrainBank With David Robles and Jacob Ellen
Darolutamide Approved for Metastatic Castration-Sensitive Prostate Cancer
Moving Beyond Traditional Roles With AI in the Era of Precision Medicine
Building Effective AI Foundation Models at Standard Model Biomedicine With Kevin Brown and Waqas Haque, MD, MPH
Tackling Cancer-Related Stigma Through Education, Language, and Compassionate Care With Gretchen McNally, PhD, MPH, ANP-BC, AOCNP®
Improving Oncology Nurses’ Workplace Wellbeing Through Aromatherapy With Jeri Lowman, MSN, RN, BMTCN®, OCN®
World No Tobacco Day: Enhancing Tobacco Treatment Training for Oncology Professionals With Maureen O’Brien MS, RN, CNS, PMHCNS-BC, CPAHA
Optimizing Cancer Care for Older Adults With Carolina Uranga, DNP, APRN, AGCNS-BC, OCN®, NPD-BC, EBP-C
Navigating the New Era of Oncology Nursing With Natasha Pinheiro, MSN, NP, AGPCNP-BC
Real-World Trends in Biomarker Testing for Bladder Cancer With Lisa Herms, PhD
Brighter Horizons and Advances in Neuro-Oncology With Jonathan Sherman, MD, FAANS, FCNS, FACS, and Morana Vojnic, MD, MBA
Reimagining Oncology Nursing Through AI Innovations With Waqas Haque, Kathleen McGrow, Sangeeta Agarawal, and Marc Perkins-Carrillo
Voices of Change: Shaping the Future Through Oncology Nursing Advocacy With Gilanie De Castro, MSN, RN, OCN®, NE-BC, CNML
Retifanlimab-dlwr Approved for Advanced Squamous Cell Carcinoma of the Anal Canal
Exploring the Impact of Discrimination on Inflammation in Black Breast Cancer Survivors With Chi-Chen Hong, PhD
Telisotuzumab Vedotin-tllv Receives Accelerated Approval for High c-Met Non-Squamous NSCLC
Belzutifan Approved for Advanced Pheochromocytoma and Paraganglioma
Restoring Sensation, Reclaiming Self: Nerve-Sparing Mastectomy and Breast Reconstruction With Valerie Brutus, MD, FACS
From Resettlement to Recovery: Meeting the Unique Healthcare Needs of Refugee Women With Connie Visovsky, PhD, RN, ACNP, FAAN
From Stigma to Strength: Shifting the Narrative in Cervical Cancer Care With Gretchen McNally, PhD, MPH, ANP-BC, AOCNP®
The Future Is Here: Integrating AI Into Oncology Nursing With Martin Michalowski, PhD, FAMIA, FIAHSI
Getting to the Heart of Women’s Heart Health With Jasmin Hundal, MD, MS, MPH
Avutometinib and Defactinib Granted Accelerated Approval for KRAS-Mutated Low-Grade Serous Ovarian Cancer
Navigating the Spectrum of VHL Care: Advances, Genetics, and Patient Perspectives
Fueling the Future of Oncology Nursing: The Impact of a Postdoctoral Research Fellowship With Eileen Hacker, PhD, APRN, AOCN®, FAAN
Melanoma Monday: Shining a Light on Awareness, Prevention, and Breakthroughs in Care With Matthew Hadfield, DO
What the Oncology Field Can Learn from The White Lotus
Penpulimab-kcqx Approved for Non-Keratinizing Nasopharyngeal Carcinoma
World Health Day: Advancing Research and Creating a Hopeful Future
Harnessing AI for Early Lung Cancer Detection: Qure.ai’s Innovations and Impact
Elevating Minoritized Voices: Building Bridges to Equitable Oncology Care With Megan-Claire Chase and Jasmin Hundal, MD, MS, MPH
AML Awareness Day: Evolving Treatment Paradigms and Future Directions With Tristan E. Knight, MD
Testicular Cancer Awareness Month: Enhancing Education by Meeting Young Men Where They Are With Eric Zack, DNP, RN, ACNP-BC
Theranostics in Prostate Cancer: Transforming Treatment With Precision Medicine
Bridging the Gap Between Academic and Community Oncology Through Innovative Education With Waqas Haque, MD, MPH, and Mohammad Jahanzeb, MD
Nivolumab and Ipilimumab Approved for Advanced Hepatocellular Carcinoma
Head and Neck Cancer Awareness Month: Advocating for Increased Research Funding Across the Spectrum of Care With Nagashree Seetharamu, MD
Nivolumab and Ipilimumab Approved for MSI-H/dMMR Colorectal Cancer
Additional Advances in Relapsed/Refractory Multiple Myeloma Research and Clinical Trials With Rahul Banerjee, MD, FACP
Esophageal Cancer Awareness Month: Expanding Treatment Options and Exploring New Directions With Harry Yoon, MD
Durvalumab Approved for Muscle Invasive Bladder Cancer
FDA Expands Indication for Lutetium Lu 177 Vipivotide Tetraxetan in PSMA-Positive mCRPC
Predicting Outcomes After CAR T-Cell Therapy: A Novel Scoring System Assessing Physical Function With Megan Herr, PhD
FDA Approves Cabozantinib for Pancreatic and Extra-Pancreatic Neuroendocrine Tumors
National Doctors’ Day: Honoring Service, Addressing Well-Being With Jafar Al-Mondhiry, MD, MA
Clinic Conversation of the Week: How to Talk With Patients About Second Primary Malignancies and T-Cell Lymphoma Risks After CAR T Therapy in Multiple Myeloma
Cultivating Proficiency in MRD Testing for the Management of Hematologic Malignancies
Pembrolizumab Approved for HER2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma
GenomOncology: Transforming Clinical Trial Matching Through AI With Ian Maurer and Waqas Haque, MD, MPH
Clinic Conversation of the Week: How to Talk With Patients About Personalized Neoantigen Vaccines for Renal Cell Carcinoma
Rare Disease Day: Generating Change Through Patient-Centered Care
Fellow of the Month: Meet Mehndi Dandwani, MD
Additional Advances in Stem Cell Mobilization Research and Clinical Trials in Multiple Myeloma With Hamza Hashmi, MD
Clinic Conversation of the Week: How to Talk With Patients About the CheckMate 8HW Trial in MSI-High/dMMR Metastatic Colorectal Cancer
International Women’s Day: Accelerating the Push for Progress With Lauren Ghazal, PhD, FNP-BC, and Farnoosh Nik-Ahd, MD
Revolutionizing Melanoma Treatment: The Technological Breakthrough of Tumor-Infiltrating Lymphocyte Therapy
Clinic Conversation of the Week: How to Talk With Patients About the FDA Approval of Datopotamab Deruxtecan for Breast Cancer
Additional Advances in Renal Cell Carcinoma Research and Clinical Trials With Nazy Zomorodian, NP, RNC, MSN, CUNP, CCRC
The Evolving Landscape of Oncology Drug Approvals: Breaking Down the FDA’s New Guidance With Harpreet Singh, MD
Clinic Conversation of the Week: How to Talk to Patients About Talquetamab and Teclistimab for Multiple Myeloma
Vimseltinib Approved for Symptomatic Tenosynovial Giant Cell Tumor
National Cancer Prevention Month: Innovations and Initiatives in Cancer Screening With Sally Werner, RN, BSN, MSHA
Brentuximab Vedotin in Combination with Lenalidomide and Rituximab Approved for Relapsed or Refractory Large B-Cell Lymphoma
The Cutting Edge of Cell and Gene Therapy: Inside Roswell Park’s GMP Engineering and Cell Manufacturing Facility (GEM) With Christopher Choi, MD
Treosulfan Plus Fludarabine Approved as alloHSCT Preparative Regimen for AML and MDS
From Glass Slides to AI: How Digital Pathology and MRD Testing Are Transforming Cancer Care With Osama Khan, MD, and Waqas Haque, MD, MPH
Fellow of the Month: Meet Wint Yan (Arthur) Aung, MD
New Frontiers in 2025: Advancing Patient-Centered Cancer Care and Health Equity With AI
Additional Advances in Hemophilia Research and Clinical Trials With Guy Young, MD
Amplifying Nursing Proficiency for the Management of Immune-Related Adverse Events
How AI Is Revolutionizing Precision Oncology With Ian Maurer and Jasmin Hundal, MD, MS, MPH
The Strength of Community: Building Careers in Hematology With the ASH Trainee Council With Kaitlyn Dykes, MD, and Maya Abdallah, MD
Acalabrutinib Plus Bendamustine and Rituximab Approved for Previously Untreated Mantle Cell Lymphoma
Mendel AI: Enhancing Clinical Data Processing for Empowered Clinical Decision Making With Kristin Maloney, MS, BSN, RN, OCN®, and Waqas Haque, MD, MPH
Clinic Conversation of the Week: How to Talk to Patients About Imlunestrant for Advanced Breast Cancer
Adherence and Treatment Tolerability in Breast Cancer: A Patient-Centered Approach to Improving Outcomes With Erica Fortune, PhD
Understanding the Role of Social Determinants of Health in Multiple Myeloma Care With Catherine Forbes, PharmD
What Oncologists and “Mathletes” Have in Common During 2025
Clinic Conversation of the Week: How to Talk to Patients About Ponsegromab for Cancer Cachexia
Venetoclax for Enhancing Immune Function in CLL: Insights From Multiomic Evaluation With Matthew Cortese, MD, MPH
Cosibelimab: A New Option for Cutaneous Squamous Cell Carcinoma With Matthew Hadfield, DO
Nivolumab and Hyaluronidase-nvhy Approved for Subcutaneous Injection
AI Applications in Thymoma Diagnosis and Management
Encorafenib/Cetuximab/mFOLFOX6 Receives Accelerated Approval for Metastatic Colorectal Cancer With BRAF V600E Mutation
Remestemcel-L-rknd Approved for Pediatric Patients With Steroid-Refractory Acute Graft-Versus-Host Disease
Ensartinib Approved for ALK-Positive Locally Advanced or Metastatic Non–Small Cell Lung Cancer
Defining and Developing Education for Systems-Based Hematology With Richard Godby, MD
Treatment Tolerability and Income: Exploring the Patient Experience in Hematologic Malignancies With Erica Fortune, PhD
ctDNA in Breast Cancer: The Journey to Clinical Utility With Ben Park, MD, and Jasmin Hundal, MD, MS, MPH
EPCORE CLL-1: An Advance in Treating Relapsed/Refractory Chronic Lymphocytic Leukemia With Alexey Danilov, MD, PhD
Clinic Conversation of the Week: How to Talk to Patients About the Zenocutuzumab Approval for NSCLC and Pancreatic Adenocarcinoma
Cosibelimab-ipdl Approved for Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma
Strength in Motion: Improving Quality of Life in Multiple Myeloma Through Resistance Training With Janine Joseph, MS, MBA
Ontada, Microsoft, and Azure AI: Collaborating to Transform Real-Word Data Processing in Oncology
Zanidatamab: A New Frontier in Treating HER2-Positive Biliary Tract Cancer With James Harding, MD
Clinic Conversation of the Week: How to Talk to Parents About the AALL1731 Trial in Pediatric B-ALL
Durvalumab Approved for Limited-Stage Small Cell Lung Cancer
i3 Health and Oncology Data Advisor Announce Release of Dedifferentiated Liposarcoma Position Statement and Podcast
Clinic Conversation of the Week: How to Talk to Patients About the INDIGO Trial in IDH-Mutant Glioma
American Diabetes Month: Navigating the Journey With Joseph Kalis, PharmD, BCOP
Lung Cancer Awareness Month: Treatment Updates in 2024
Fellow of the Month: Meet Nida Khan, MD
Celebrating and Supporting Caregivers During National Family Caregivers Month
Recent Advances in Cancer Research and AI Applications
Advancing Clinical Expertise in the Oncologic and Pathologic Management of Triple-Negative Breast Cancer
Revumenib Approved for Relapsed or Refractory Acute Leukemia With a KMT2A Translocation
Carcinoid Cancer Awareness Month: Exploring Diagnosis, Treatment, and Patient-Centered Care
Transgender Awareness Week: Prostate Cancer Research and Insights for Compassionate Care With Stephen Freedland, MD, and Farnoosh Nik-Ahd, MD
Optimizing Clinical Strategies for Effective Management of Soft Tissue Sarcomas
Clinic Conversation of the Week: How to Talk to Patients About the BENEFIT Trial in Multiple Myeloma
Obecabtagene Autoleucel Approved for Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Elevating Clinician Competence in the Management of Early-Stage Non–Small Cell Lung Cancer
Artera: Personalizing Treatment Decisions in Prostate Cancer and Beyond With Waqas Haque, MD, MPH, and Trevor Royce, MD, MS, MPH, FASCO
InspiroGene: Revolutionizing the Cell and Gene Therapy Landscape With Joe DePinto, MBA, and Waqas Haque, MD, MPH
What the Oncology Field Can Learn From Jimmy Carter
Asciminib Receives Accelerated Approval for Newly Diagnosed Chronic Myeloid Leukemia
The KRAS Story in Lung Cancer: Dosing Lessons to Learn From the Accelerated Approval of Sotorasib With Harpreet Singh, MD, and Matthew Hadfield, DO
Opportunities for AI in Health Equity, Medical Education, and Beyond
National Breast Cancer Foundation (NBCF): Helping Women Now With Douglas Feil and Megan-Claire Chase
National Healthcare Quality Week: Listening to Patients to Improve Care Delivery With Lauren Ghazal, PhD, FNP-BC, and Matthew Hadfield, DO
Zolbetuximab-clzb Plus Chemotherapy Approved for Gastric or Gastroesophageal Junction Adenocarcinoma
Fellow of the Month: Meet Jasmin Hundal, MD, MS, MPH
Revolutionizing Cancer Diagnostics Through AI-Powered Analysis With Waqas Haque, MD, and Aamir Ehsan, MD
Advancing Clinician Expertise in Recurrent and Metastatic Head and Neck Cancer
Lobular Breast Cancer Awareness Day: Making Strides in Research With Jason Mouabbi, MD
Approval of Inavolisib: A Leap Forward in Precision Breast Cancer Therapy With Jason Mouabbi, MD
World Hospice and Palliative Care Day With Richa Thakur, MD, and Nida Khan, MD
Inavolisib Plus Palbociclib and Fulvestrant Approved for Endocrine-Resistant, PIK3CA-Mutated, HR-Positive, HER2-Negative, Advanced Breast Cancer
World Mental Health Day: Perspectives From Both Patient and Provider With Allison Rosen, MS, and Stephen Freedland, MD
Improving Confidence With BCMA-Directed Therapies in Relapsed/Refractory Multiple Myeloma
Additional Advances in Head and Neck Squamous Cell Carcinoma With Deborah Wong, MD, PhD
Nivolumab Approved for Neoadjuvant/Adjuvant Treatment of Resectable Non–Small Cell Lung Cancer
Studying Rare Cancers: Current Methodologies and Future Opportunities With Dr. Amy O’Sullivan, Dr. Nicholas Robert, Dr. Zhaohui Su, Dr. Matthew Hadfield, and Dr. Waqas Haque
Selpercatinib Approved for RET Fusion-Positive Medullary Thyroid Cancer
Osimertinib Approved for Locally Advanced, Unresectable Stage III Non–Small Cell Lung Cancer Following Chemoradiation Therapy
Childhood Cancer Awareness Month: A Primer on Pediatric Cancers With Tristan Knight, MD, FRCPC
Isatuximab-irfc Plus Bortezomib, Lenalidomide, And Dexamethasone Approved For Newly Diagnosed Multiple Myeloma
World Cancer Research Day: Trends for the Future With Allison Rosen, MS; Stephen Freedland, MD; and Waqas Haque, MD, MPH
Pain Awareness Month: A Dual Perspective on Navigating Cancer Pain With Richa Thakur, MD, and Megan-Claire Chase
Prostate Cancer Awareness Month: Overcoming Disparities With Waqas Haque, MD, MPH
Impacts of AI in the Evolving Oncology Landscape
Amivantamab-vmjw Plus Chemotherapy Approved for Non–Small Cell Lung Cancer With EGFR Exon 19 Deletions or L858R Mutations
Blood Cancer Awareness Month: Navigating Hereditary Hematologic Malignancy Genetics With Hiam Adel-Salam, MS, CGC, and Sarah Bannon, MS, CGC
Lymphoma Awareness Month: Nursing and Patient Advocacy Perspectives With Maria Badillo, MSN, RN, OCN®, CCRP, and Lauren Ghazal, PhD, FNP-BC
Pembrolizumab Plus Chemotherapy Approved for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
Ribociclib Plus Aromatase Inhibitor and Ribociclib/Letrozole Co-Pack Approved for Early High-Risk Breast Cancer
Take a Loved One to the Doctor Day With Samuel Kareff, MD, MPH, and Matthew Hadfield, DO
Prostate Cancer Awareness Month: The Urologist and Oncologist Perspectives With Stephen Freedland, MD, and Ulka Vaishampayan, MD
Enhancing Knowledge of Emerging Treatment Strategies and Latest Advances in Follicular Lymphoma Therapy
Investigating the Impact of Multiple Pharmacy Use and Medication Adherence in Colorectal Cancer With Timothy Barnett, PharmD, CSP
Additional Advances in Immune-Related Adverse Events Research and Clinical Trials With Beth Sandy, MSN, CRNP
iCAD: Creating a World Where Cancer Can’t Hide With Waqas Haque, MD, MPH, and Dana Brown
i3 Health and Oncology Data Advisor Publish Multiple Myeloma Task Force Position Statement in Blood Cancer Journal
i3 Health and Oncology Data Advisor Publish Multiple Myeloma Task Force Position Statement in Blood Cancer Journal
National Grief Awareness Day: Everyone’s Journey Is Different With Joseph Kalis, PharmD, BCOP; Megan-Claire Chase; Lauren Ghazal, PhD, FNP-BC
International Overdose Awareness Day: Erasing the Stigma With Alankrita Taneja, MD, and Matthew Hadfield, DO
AI in Pathology: Transforming Oncology Diagnosis and Treatment
Improving Understanding of Evolved Treatment Concepts and New Data in Advanced Prostate Cancer
Palliative Care and Oncology: Partners in Patient Care With Richa Thakur, MD, and Janet Abrahm, MD
Lazertinib Plus Amivantamab-vmjw Approved for Non–Small Cell Lung Cancer
Neoadjuvant/Adjuvant Durvalumab Approved for Resectable Non–Small Cell Lung Cancer
Navigating the Fellowship Application Experience With Jorge Avila, MD
Axatilimab-csfr Approved for Chronic Graft-Versus-Host Disease
#ActForHumanity: Advocating for Aid Workers on World Humanitarian Day With Alankrita Taneja, MD, and Matthew Hadfield, DO
World Breast Cancer Research Day: Making Strides in Neuropathy Research With Megan-Claire Chase and Connie Visovsky, PhD, RN, ACNP, FAAN
Summer Sun Safety Month: How to Stay Healthy While Enjoying the Sun With Tristan Knight, MD, FRCPC, and Matthew Hadfield, DO
Enhancing Value-Based Care and Treatment of Newly Diagnosed Multiple Myeloma
Vorasidenib Approved for Grade 2 Astrocytoma or Oligodendroglioma With a Susceptible IDH1 or IDH2 Mutation
Statistically Significant Knowledge Gains for Esophagogastric Cancer Care
The Digital Fingerprint: Accelerating Personalized Drug Discovery and Development With Luis Valente and Waqas Haque, MD, MPH
Optimizing Sacituzumab Govitecan Tolerability in Early TNBC With Early Management: Antonio Llombart-Cussac, MD
Afamitresgene Autoleucel Granted Accelerated Approval as First Gene Therapy for Synovial Sarcoma
Dostarlimab-gxly Plus Chemotherapy Receives Expanded Approval for Endometrial Cancer
Interpreting PSA Values in Transgender Women for Optimal Prostate Cancer Screening With Stephen Freedland, MD, and Farnoosh Nik-Ahd, MD
World Lung Cancer Day: A Glimpse Into Hope for the Future
New Updates on the Evolving Landscape of AI in Oncology
Leading Transplantation Support and Research at NMDP and CIBMTR With Richa Thakur, MD, and Steven Devine, MD
Daratumumab and Hyaluronidase-fihj Approved for Newly Diagnosed Multiple Myeloma
National Minority Mental Health Awareness Month: What Needs to Change?
Sarcoma Awareness Month: Partnering to Provide Optimal Outcomes With Joseph Kalis, PharmD, BCOP, and Richard Riedel, MD
Enhancing Knowledge of Advanced Renal Cell Carcinoma Treatment and Patient Care
CaringBridge: Ensuring No One Goes Through a Health Journey Alone With Tia Newcomer, CEO
Reimagining Surgery Through AI and Computer Vision Technology With Tamir Wolf, MD, PhD, and Waqas Haque, MD, MPH
Prizes, Prose Messages, and Prior-Auth Battles: AI in Oncology is Here to Stay
Prizes, Prose Messages, and Prior-Auth Battles: AI in Oncology is Here to Stay
Oncology Data Advisor® Receives APEX Award of Excellence for Artificial Intelligence Blog and Podcast Series
Oncology Data Advisor® Receives APEX Award of Excellence for Artificial Intelligence Blog and Podcast Series
Exploring Association of FGFR3 Alterations in Urothelial Cancer With Arlene Siefker-Radtke, MD
Biomarker Documentation in the Community Setting: Improving Clinical Decision Support With Daniel Rubin, PharmD
Community Oncology Pharmacists: Their Crucial Role and Clinical Impact With Andrea Roman, PharmD, BCOP
Investigating Axicabtagene Ciloleucel for Relapsed/Refractory Central Nervous System Lymphoma With Lakshmi Nayak, MD
Updated Results from the SPOTLIGHT and EV-302 Trials at ASCO With Ahsan Arozullah, MD, MPH
WoMMen Trekking Peru: An Adventure to Support Myeloma Research With Gurbakhash Kaur, MD
Cancer and Careers: Empowering People with Cancer to Thrive in the Workplace With Rebecca Nellis, MPP
Worth the Wait: Supporting Young Adult Cancer Survivors on the Path to Parenthood With Mike Scherer
The Latest Data on Zanidatamab for HER2-Positive Biliary Tract Cancer With Shubham Pant, MD, MBBS
Intuitively Designing Clinical Trials to Empower Patients With Ishwaria Subbiah, MD
Combating Health Disparities Through More Equitable Screening With Chyke Doubeni, MD, MPH
The NADINA Trial: A Paradigm Shift in Melanoma Treatment With Matthew Hadfield, DO
Multicancer Early Detection: What's Your Opinion? With Chyke Doubeni, MD, MPH
An Innovative Wellness and Professional Development Curriculum for Fellows With Thejal Srikumar, MD
Best of ASCO 2024: What Patients Need to Know
Best of ASCO 2024: What Patients Need to Know
Highlights of Multiple Myeloma Research Presented at ASH With Urvi Shah, MD
Implementing a Novel Research Methods Training Curriculum for Fellows With Noha Sharafeldin, MD, MSc, PhD, and Waqas Haque, MD, MPH
Thinking Globally: Broadening Cancer Treatment Equity Around the World With Gilberto Lopes, MD, and Samuel Kareff, MD, MPH
The Fellow on Call and Fellowship Research at ASCO With Ronak Mistry, DO, and Vivek Patel, MD
Representing Symptom Research and Nursing at ASCO With Natalie Jackson-Carroll, PhD, APRN, FNP-C
Piloting Palliative Care Education for Fellows With Jessica Bauman, MD
Piloting Palliative Care Education for Fellows With Jessica Bauman, MD
The Sarcoma Foundation of America: Advocating for Sarcoma Research With Brandi Felser and Waqas Haque, MD, MPH
Epcoritamab-bysp Granted Accelerated Approval for Relapsed or Refractory Follicular Lymphoma
Advocates for Universal DPD/DPYD Testing With Karen Merritt and Dan Hertz, PharmD, PhD
Analyzing Enzalutamide Patient-Reported Outcomes and QOL in the EMBARK Trial With Stephen Freedland, MD
Effective Care for Substance Use Disorders in Cancer: The Advanced Practice Nurse Perspective With Gretchen McNally, APRN-CRP
Addressing Barriers to Transplantation Accessibility With Monzr Al Malki, MD, and Richa Thakur, MD
Improving Long-Term Survivorship Care in Head and Neck Cancer With Erica Fortune, PhD
Oncology Data Advisor at ASCO 2024
Adagrasib Plus Cetuximab Granted Accelerated Approval for KRAS G12CL–Mutated Colorectal Cancer
Count Me In: Partnering With Patients to Accelerate the Pace of Cancer Research With Melissa Mirick
Qure.ai: Improving Early Lung Cancer Detection Through AI-Powered Solutions with Ranjana Devi and Waqas Haque, MD, MPH
Qure.ai: Improving Early Lung Cancer Detection Through AI-Powered Solutions with Ranjana Devi and Waqas Haque, MD, MPH
Developing a Polygenic Risk Score for TNBC Risk Assessment in Black Women With Holly Pederson, MD, and Elisha Hughes, PhD
Harnessing the Power of AI for Cancer Detection
Blue Faery: Improving Liver Cancer Care Through Education and Research With Andrea Wilson Woods
Pembrolizumab With Chemotherapy Approved for Primary Advanced or Recurrent Endometrial Carcinoma
Highlights of Brain Tumor and CNS Research at ASCO With Morana Vojnic, MD, MBA
Blinatumomab Approved as Consolidation for CD19-Positive, Philadelphia Chromosome–Negative B-Cell Precursor Acute Lymphoblastic Leukemia
Artful Oncology: A Psychosocial Oncology Curriculum for Hematology/Oncology Fellows With Jafar Al-Mondhiry, MD, MA
Representing Fellows in Evidence-Based Wellness Interventions With Andrew Hearn, MD, MSCI
Durvalumab With Chemotherapy Approved for Mismatch Repair–Deficient Primary Advanced or Recurrent Endometrial Cancer
The Fellows Forum Live From ASCO 2024 With Samuel Kareff, MD, MPH; Waqas Haque, MD, MPH; and Matthew Hadfield, DO
Join Our New Online Community for Hematology/Oncology Fellows!
Repotrectinib Granted Accelerated Approval for NTRK Gene Fusion–Positive Solid Tumors
Repotrectinib Granted Accelerated Approval for NTRK Gene Fusion–Positive Solid Tumors
Assessing Risk of Myelosuppression With PARP Inhibitors in Prostate Cancer With Karan Jatwani, MBBS
Selpercatinib Granted Traditional Approval for RET Fusion–Positive Thyroid Cancer
Understanding Cardiotoxicity Risk with BTK Inhibitors in Hematologic Cancers: Muhammad Salman Faisal, MBBS
The Fellows Forum at ASCO 2024
Predicting Immunotherapy Benefit in Lung Cancer and Beyond With Ofer Sharon, MD
The Fellows Forum at ASCO 2024
Highlights of Sarcoma Research Presented at ASCO 2024 With Richard Riedel, MD
Exploring the Tumor Microenvironment of Invasive Lobular Carcinoma With Jason Mouabbi, MD
Imetelstat Approved for Low- to Intermediate-1–Risk Myelodysplastic Syndromes
A Precision Health Approach to Post-Treatment Comorbid Diabetes in Cancer With Marilyn Hammer, PhD, DC, RN, FAAN
Supporting Nurses Returning to Work After Cancer Diagnosis With Kai-Lin You
You’re Invited! Live Webinar on Von-Hippel Lindau Disease
Food for Thought: Nutrition in Vulnerable Cancer Populations With Mariah Jackson and Caitlin Benda
Starting the Conversation: End-of-Life Communication in Oncology Nursing With Stacey Simons, NP, AGPC-BC, ACHPN, AOCNP
Lisocabtagene Maraleucel Approved for Relapsed or Refractory Mantle Cell Lymphoma
Mitigating Financial Toxicity Experienced by Cancer Survivors With Dan Sherman, LPC
Selpercatinib Granted Accelerated Approval for Pediatric Patients With RET-Altered Metastatic Thyroid Cancer or Solid Tumors
OurBrainBank: Creating Change in Glioblastoma Treatment With Kelli Duprey and David Robles
Championing Policy Advocacy in Cancer: The Patient and Nurse Perspectives With Carley VonHeeder and Gilanie De Castro, MSN, RN, OCN®, NE-BC, CNML
“Speed Dating”: Bridging the Gap Between DNP and PhD Nurses With James Simmons and Cheryl Le Huquet
Climate Change and Healthcare: What We Can Do to Help With AnnMarie Walton, PhD, MPH, RN; Ryne Wilson, DNP, RN, OCN®; and Stacy Stanifer, PhD, APRN, AOCNS®
Lisocabtagene Maraleucel Granted Accelerated Approval for Follicular Lymphoma
Lisocabtagene Maraleucel Granted Accelerated Approval for Follicular Lymphoma
Updates on Cellular Therapy and Roles of AI in Clinical Practice
The Way Ahead: The Convergence of Technology and Cancer Care, May 2024 Edition
Celebrating Oncology Nursing and Research With Margaret Barton-Burke, PhD, RN, FAAN, ONS Lifetime Achievement Award Recipient
Incorporating Patient-Reported Outcomes in Oncology Research With Elaine Novakovich MSN, RN, and Theresa Yu, MSN, RN, OCN®
Brain Tumor Awareness Month: Providing Hope Through Research With Matthew Hadfield, DO; Morana Vojnic, MD, MBA; and Jethro Hu, MD
Brain Tumor Awareness Month: Providing Hope Through Research With Matthew Hadfield, DO; Morana Vojnic, MD, MBA; and Jethro Hu, MD
Igniting the Extraordinary Through AYA and LGBTQ+ Research at ONS With Lauren Ghazal, PhD, FNP-BC
Approval of Tarlatamab-dlle for Subsequent-Line Treatment of Extensive-Stage Small Cell Lung Cancer
The Power of Persistence and Perspective: Igniting the Extraordinary at ONS With Kelsey Tainsh, BS
Tackling Disparities Experienced by LGBTQ+ Cancer Survivors With Kelly Tan, PhD, RN
Highlights of ONS Congress 2024 With Maria Badillo, MSN, RN, OCN®, CCRP
The Future of Oncology Research: Cutting-Edge Approaches Using AI With Maxim Topaz, PhD, RN, MA
Discussing Cancer Fatalism and Risky Health Behaviors with Maryum Zaidi, PhD, RN
Smith Center for Healing and the Arts: Promoting Healing and Wellness During Cancer Erin Price, LICSW, OSW-C, and Laura Pole, RN, MSN
Launching the Genetic Cancer Prevention Clinic With Kathy Pratt, BSN, RN, OCN®, CBCN®, ONN-CG, and Megan Temple, BSN, RN, CNOR, CBCN®, HWNC-BC
Cancer Support Community Joins Oncology Data Advisor® Editorial Board
Providing Evidence to Support New Product Introductions in Nursing With Colleen O’Leary, DNP, RN, AOCNS®, EBP-C
Bridging Oncology Nursing Learning Gaps Through an Advanced Practice Provider Fellowship With Amelia Cataldo, DNP, RN, CPNP-AC, CCRN
Welcoming the New Oncology Nursing Society President: Jessica MacIntyre, DNP, MBA, APRN, NP-C, AOCNP®
Oncology Data Advisor at the Oncology Nursing Society (ONS) Congress 2024
Additional Advances in Multiple Myeloma Research and Clinical Trials With Rahul Banerjee, MD, FACP
Recurrent/Metastatic HNSCC: Answers To Frequently Asked Questions With Assuntina G. Sacco, MD
Every Cure: Unlocking Drug Potential Through Artificial Intelligence With Waqas Haque, MD, MPH, and Tracey Sikora, Co-Founder
Acute Myeloid Leukemia (AML) Awareness Day: Evolving Treatment Directions With Dr. Tristan Knight, Dr. Richa Thakur, and Dr. Joseph Kalis
Testicular Cancer Awareness Month: Improving Detection, Management, and Survivorship With Samuel Kareff, MD, MPH; Waqas Haque, MD, MPH; and Matthew Hadfield, DO
Tisotumab Vedotin-tftv Approved for Metastatic Cervical Cancer
Tovorafenib Approved for BRAF-Altered Pediatric Low-Grade Glioma
Lutetium Lu 177 Dotatate Approved for Pediatric Patients With GEP-NETS
Celebrating Head and Neck Cancer Awareness Month With Samuel Kareff, MD, MPH; Matthew Hadfield, DO; and Nagashree Seetharamu, MD
Nogapendekin Alfa Inbakicept-pmln Approved for BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer
Advancing Precision Oncology Through Artificial Intelligence
Advancing Precision Oncology Through Artificial Intelligence
Alectinib Approved for Adjuvant Treatment for ALK-Positive Non–Small Cell Lung Cancer
Esophageal Cancer Awareness Month: Treatment Advances and Tools for Maximizing Tolerability With Joseph Kalis, PharmD, BCOP; Matthew Hadfield, DO; Samuel Kareff, MD, MPH
Linvoseltamab for Relapsed/Refractory Multiple Myeloma: Updates on the LINKER-MM1 Trial From AACR 2024 With Alankrita Taneja, MD, and Sundar Jagannath, MD
Linvoseltamab for Relapsed/Refractory Multiple Myeloma: Updates on the LINKER-MM1 Trial From AACR 2024 With Alankrita Taneja, MD, and Sundar Jagannath, MD
Improving Breast Cancer Surgical Outcomes With Lymphovenous Bypass With Jason Mouabbi, MD; Valerie Brutus, MD, FACS; and Elizabeth Stirling Craig, MD
Additional Advances in HER2-Positive Metastatic Colorectal Cancer Research and Clinical Trials With Christopher Lieu, MD
Fighting Hereditary Colorectal Cancer Through Genetic Counseling With Catherine Skefos, MA, MS, CGC, and Julie Moskowitz, MS
Fam-Trastuzumab Deruxtecan-nxki Receives Accelerated Approval for HER2-Positive Solid Tumors
International Women’s Day: Perspectives in Medicine, Nursing, and Fellowship From Richa Thakur, Nida Khan, Lauren Ghazal, and Gurbakhash Kaur
AYA Cancer Awareness Week: Creating Welcoming Spaces for Support and Advocacy With Dr. Lauren Ghazal, Megan-Claire Chase, and Allison Rosen
Additional Advances in Soft Tissue Sarcoma With Brian Rubin, MD, PhD
Additional Advances in aTTP Research and Clinical Trials With Spero Cataland, MD
Predicting Immune-Related Adverse Events Through Machine Learning With OncoHost: Dr. Waqas Haque, Dr. Matthew Hadfield, and Dr. Ofer Sharon
Creating Educational Opportunities During Fellowship: Board Exam Prep, Live Meetings, and Beyond With Samuel Kareff, MD, MPH, and Matthew Hadfield, DO
Thirty Years in the Making: The Groundbreaking Approval of Lifileucel for Metastatic Melanoma With Matthew Hadfield, DO, and Richard Carvajal, MD
Celebrating National Doctor’s Day With Samuel Kareff, MD, MPH, and Matthew Hadfield, DO
Kidney Cancer Awareness Month: Spotlight on Genetic Counseling With Hiam Abdel-Salam, MS, CGC, and Donika Saporito, MS
A Case in Contrasts: How Should the Media Talk About Cancer Diagnoses?
Additional Advances in Esophagogastric Cancer Research and Clinical Trials With Jaffer Ajani, MD
An Introduction to Genetic Counseling With Hiam Abdel-Salam, MS, CGC, and Catherine Skefos, MA, MS, CGC
Emerging Technologies in Therapeutics and Diagnostics
Kidney Cancer Awareness Month: Discovering Clinical Strategies to Improve Outcomes With Dr. Samuel Kareff, Dr. Waqas Haque, and Dr. Ulka Vaishampayan
Kidney Cancer Awareness Month: Discovering Clinical Strategies to Improve Outcomes With Dr. Samuel Kareff, Dr. Waqas Haque, and Dr. Ulka Vaishampayan
Mirvetuximab Soravtansine-gynx Approved for FRα-Positive, Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Multiple Myeloma Awareness Month 2024: What Patients Need to Know
Thirty Years in the Making: The Groundbreaking Approval of Lifileucel for Metastatic Melanoma With Matthew Hadfield, DO, and Richard Carvajal, MD
Discovering Research Advances in Mesothelioma With Samuel Kareff, MD, MPH, and Estela Rodriguez, MD, MPH
Acquiring Expertise for Improved Patient Outcomes in Immune Thrombocytopenia
Ponatinib/Chemotherapy Granted Accelerated Approval for Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
Rare Disease Day 2024: A Live Panel Discussion With Dr. Rahul Banerjee, Matthew Hadfield, Joseph Kalis, and Nagashree Seetharamu
Emerging Technologies in Therapeutics and Diagnostics
Advanced Renal Cell Carcinoma: Treatment Insights
